Ring fusion strategy for the synthesis of anthra[2,3-d ]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents

Chun Liang Chen, Fei Lan Liu, Chia Chung Lee, Tsung Chih Chen, Wen Wei Chang, Jih Hwa Guh, Ahmed Atef Ahmed Ali, Deh Ming Chang, Hsu Shan Huang

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The efficient synthesis of mono-substituted anthraquinones and ring fusion into anthra[2,3-d]oxazole-2-thione-5,10-dione derivatives were developed, and all the compounds were tested for their cytotoxicity against PC-3 cancer cell lines. Compounds 8, 14, 17 and 23 were selected by the NCI and 12, 17 and 19 were evaluated for topoisomerase I-mediated DNA relaxation. Among them, 17 appeared to be the most active compound of this series and not only showed higher inhibition when indicated from the low IC50values against PC-3 cancer cell line but also attenuated the in vitro topoisomerase I-mediated DNA relaxation at low micromolar concentrations. All test compounds exhibited different cytostatic and cytotoxic activities for further developing potential anticancer drugs.

Original languageEnglish
Pages (from-to)30-38
Number of pages9
JournalEuropean Journal of Medicinal Chemistry
Volume87
DOIs
Publication statusPublished - Nov 24 2014

Keywords

  • cell panel assay
  • mediated DNA relaxation NCI 60
  • Topoisomerase I

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Ring fusion strategy for the synthesis of anthra[2,3-d ]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents'. Together they form a unique fingerprint.

  • Cite this